Diagnosis of Inflammatory Bowel Disease

Starting soon

Conditions studied: Inflammatory Bowel Disease (IBD)

In brief

* To quantify the expression of Nuclear enriched abundant transcript 1 (NEAT1) and Anti-sense Non RNA in the INLK4 locus (ANRIL) to determine their potential role as non invasive diagnostic biomarkers in inflammatory bowel disease. * To evaluate the correlation between the studied biomarkers and both the clinical presentation of the patients and the inflammatory mediators like Nuclear factor κB (NF-KB) signaling pathway.

Key facts

Study ID

NCT07400211

Run by

Assiut University

People needed

62

Starts

2026-04-01

Expected to finish

2028-06-01

Last updated by the study team

2026-02-11

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Newly histopathologicaly diagnosed IBD

You may not qualify if…

• Patients with serious complications as intestinal obstruction, perforation, polyps or colorectal carcinoma
• Patients who are taking NSAIDs or Immunosuppressive drugs
• Patients who are having other autoimmune disorders
• Patients with Chronic infections as TB or other diseases
• Patients with a history of allergy
• Pregnant or Lactating women

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.